Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …

Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …

Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …

Introduction: Thyroid cancer is one of the most common carcinomas diagnosed in
adolescents and young adults, with a rapidly rising incidence for the past three decades …

Purpose: Controversies remain over the actual risk of developing a second primary
malignancy (SPM) as a consequence of I-131 treatment in patients with differentiated thyroid …

We examined the effects of I-131 therapy for thyroid cancer on female and male gonads and
pregnancy outcome. After an extensive review of the published literature we concluded that …

Simple Summary This meta-analysis of 22 articles investigated whether thyroidectomy or
radioactive iodine treatment (RAIT) in patients with differentiated thyroid cancer was …

Pregnancy Outcome After I-131 Therapy for Patients With Thyr... : Medicine Pregnancy
Outcome After I-131 Therapy for Patients With Thyroid Cancer: A Nationwide Population-Based …

Purpose Thyroid cancer is the most rapidly increasing cancer in the USA, affects a young,
mostly female population, and has high survival. The aim of this study was to determine if …

During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …